Pre-clinical studies highlighted the efficacy of small molecule mimetics of BDNF, such as deoxygedunin and N-acetyl-serotonin, against AD neuropathology (Jang et al., 2010a, 2010b; Jang et al., 2010a, 2010b). The gene discussed is BDNF; the disease is Alzheimer disease.